"We specialize in clinical research studies involving paid volunteers. Want to get involved in a clinical trial? Check out our website to view our current studies and see if you may qualify for a trial. Clinical trials allow medical researchers to evaluate drug effectiveness and safety in a controlled environment. Carolina's GI Research is dedicated to conducting safe and successful studies. Past participants often return to participate in more studies because they enjoyed their experience."

During the past decade, Carolina's GI Research, LLC conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 2 clinical trials were completed, i.e. on average, 22.2% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Carolina's GI Research, LLC" #1 sponsor was "Galapagos NV" with 3 trials, followed by "Gilead Sciences" with 2 trials sponsored, "Adare Pharmaceuticals, Inc." with 1 trials sponsored, "Freenome Holdings Inc." with 1 trials sponsored and "Guardant Health, Inc." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Carolina's GI Research, LLC" #1 collaborator was "Gilead Sciences" with 3 trials as a collaborator, "Galapagos NV" with 1 trials as a collaborator, "Novo Nordisk A/S" with 1 trials as a collaborator and "Premier Research Group plc" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Carolina's GI Research, LLC" are "Colorectal Cancer" (2 trials), "Crohn's Disease" (2 trials), "Ulcerative Colitis" (2 trials), "Adenoma" (1 trials) and "Colon Cancer" (1 trials). Many other conditions were trialed in "Carolina's GI Research, LLC" in a lesser frequency.

Most popular intervention types in "Carolina's GI Research, LLC" are "Drug" (7 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Filgotinib" (4 trials), "Placebo" (3 trials), "APT-1011" (1 trials), "Cilofexor (CILO)/Firsocostat (FIR)" (1 trials) and "Freenome test" (1 trials). Other intervention names were less common.

The vast majority of trials in "Carolina's GI Research, LLC" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Carolina's GI Research, LLC". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 4 completed trials in Carolina's GI Research, LLC, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Carolina's GI Research, LLC, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".